3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
19
Carcinoma, Hepatocellular
15
Brain Neoplasms
12
Breast Neoplasms
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Lung Neoplasms
5
Neoplasms
4
Recurrence
3
Colorectal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neuroma, Acoustic
2
NSCLC
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Glioblastoma
2
Esophageal Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1
Stage IA - IB Non Small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Spine Metastasis
1
Spinal Neoplasms
1
Spinal Bone Metastases
1
Solid Tumor
1
Sarcoma
1
Rare Diseases
1
Radiotherapy
1
Interventions
Injections
4
apatinib
3
Cisplatin
3
Capecitabine
3
toripalimab
2
alpha-Synuclein
2
Oxaliplatin
2
Gemcitabine
2
Drug Therapy
2
Docetaxel
2
trametinib
1
tislelizumab
1
tesetaxel
1
surufatinib
1
spartalizumab
1
pyrotinib
1
pemigatinib
1
pembrolizumab
1
nimotuzumab
1
mogamulizumab
1
irinotecan sucrosofate
1
fludarabine
1
famitinib
1
dalpiciclib
1
camrelizumab
1
YM753 compound
1
Vemurafenib
1
Taxes
1
SHR-1701
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Solid Tumor
×
Radiosurgery
×
Clear all
NCT04407897
2022-04-28
SOFT
Herlev Hospital
Phase NA
Unknown
121 enrolled